|
Ipatasertib
- 英文名称：Ipatasertib
- 品牌：WYTSCI
- 产地：进口
- 型号：1MG
- 货号：WT-AY-B11387
- cas：1001264-89-6
- 价格： ￥1/mg
- 发布日期： 2025-04-10
- 更新日期： 2025-12-08
产品详请
| 产地 | 进口 |
| 品牌 | WYTSCI |
| 货号 | WT-AY-B11387 |
| 用途 | 科研检测 |
| 英文名称 | Ipatasertib |
| 包装规格 | 1MG |
| CAS编号 | 1001264-89-6 |
| 别名 | Ipatasertib |
| 纯度 | 98+% |
| 分子式 | |
| 是否进口 | 是 |
纯度:98% by HPLC;NMR (Conforms)
分子式:C24H32ClN5O2
分子量:458.00
溶剂:DMSO (25 mg/ml) Ethanol (20 mg/ml)
性状:Off-white of pale pink solid
存储:-20°C
Activity (short version):Pan-AKT inhibitor
Function / Pharmacology:Ipatasertib is a selective (against a panel of 230 kinases) and potent pan-Akt inhibitor (IC50s: Akt1 = 5 nM, Akt2 = 18 nM, Akt3 = 8 nM).1 It displayed efficacy in xenograft models of prostate, breast, ovarian, colorectal, non-small cell lung, glioblastoma, and melanoma cancers.2 In clinical trials.
分子式:C24H32ClN5O2
分子量:458.00
溶剂:DMSO (25 mg/ml) Ethanol (20 mg/ml)
性状:Off-white of pale pink solid
存储:-20°C
Activity (short version):Pan-AKT inhibitor
Function / Pharmacology:Ipatasertib is a selective (against a panel of 230 kinases) and potent pan-Akt inhibitor (IC50s: Akt1 = 5 nM, Akt2 = 18 nM, Akt3 = 8 nM).1 It displayed efficacy in xenograft models of prostate, breast, ovarian, colorectal, non-small cell lung, glioblastoma, and melanoma cancers.2 In clinical trials.
